Log in

NASDAQ:AGTCApplied Genetic Technologies Stock Price, Forecast & News

+0.60 (+10.29 %)
(As of 07/3/2020 09:28 AM ET)
Today's Range
Now: $6.43
50-Day Range
MA: $5.19
52-Week Range
Now: $6.43
Volume424,460 shs
Average Volume665,766 shs
Market Capitalization$165.64 million
P/E RatioN/A
Dividend YieldN/A
Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. The company's advanced product candidates consist of three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in Phase I/II clinical trials; and achromatopsia that is in Phase I/II clinical trials. The company also has initiated one preclinical program in otology and three preclinical programs in targeting central nervous system disorders, including one in adrenoleukodystrophy. Applied Genetic Technologies Corporation has collaboration agreements with Synpromics Limited and University of Florida; Bionic Sight, LLC; and Otonomy, Inc. The company was founded in 1999 and is headquartered in Alachua, Florida.
Read More
Applied Genetic Technologies logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 3.0Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.63 out of 5 stars

Industry, Sector and Symbol

Industry Biological products, except diagnostic
Current SymbolNASDAQ:AGTC



Sales & Book Value

Annual Sales$41.69 million
Book Value$4.33 per share


Net Income$-2,010,000.00


Market Cap$165.64 million
Next Earnings Date9/24/2020 (Estimated)

Receive AGTC News and Ratings via Email

Sign-up to receive the latest news and ratings for AGTC and its competitors with MarketBeat's FREE daily newsletter.

Applied Genetic Technologies (NASDAQ:AGTC) Frequently Asked Questions

How has Applied Genetic Technologies' stock been impacted by COVID-19 (Coronavirus)?

Applied Genetic Technologies' stock was trading at $3.84 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, AGTC shares have increased by 67.4% and is now trading at $6.43. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Applied Genetic Technologies?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Applied Genetic Technologies in the last year. There are currently 7 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Applied Genetic Technologies.

When is Applied Genetic Technologies' next earnings date?

Applied Genetic Technologies is scheduled to release its next quarterly earnings announcement on Thursday, September 24th 2020. View our earnings forecast for Applied Genetic Technologies.

How were Applied Genetic Technologies' earnings last quarter?

Applied Genetic Technologies Corp (NASDAQ:AGTC) posted its quarterly earnings data on Wednesday, May, 13th. The biotechnology company reported ($0.50) earnings per share for the quarter, topping the consensus estimate of ($0.55) by $0.05. View Applied Genetic Technologies' earnings history.

What price target have analysts set for AGTC?

7 brokers have issued 12 month price objectives for Applied Genetic Technologies' shares. Their forecasts range from $10.00 to $25.00. On average, they anticipate Applied Genetic Technologies' share price to reach $16.14 in the next twelve months. This suggests a possible upside of 151.1% from the stock's current price. View analysts' price targets for Applied Genetic Technologies.

Has Applied Genetic Technologies been receiving favorable news coverage?

Press coverage about AGTC stock has trended negative recently, according to InfoTrie. The research group identifies negative and positive press coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Applied Genetic Technologies earned a news impact score of -2.8 on InfoTrie's scale. They also assigned news stories about the biotechnology company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the stock's share price in the near term. View the latest news about Applied Genetic Technologies.

Who are some of Applied Genetic Technologies' key competitors?

What other stocks do shareholders of Applied Genetic Technologies own?

Who are Applied Genetic Technologies' key executives?

Applied Genetic Technologies' management team includes the following people:
  • Ms. Susan B. Washer, Pres, CEO & Director (Age 59, Pay $777.27k)
  • Dr. Mark S. Shearman, Chief Scientific Officer (Age 60, Pay $538.93k)
  • Dr. Matthew Feinsod, Exec. VP of Global Strategy & Devel. (Age 49, Pay $711.2k)
  • Dr. Nicholas Muzyczka, Co-Founder
  • Dr. Barry J. Byrne, Co-Founder

What is Applied Genetic Technologies' stock symbol?

Applied Genetic Technologies trades on the NASDAQ under the ticker symbol "AGTC."

How do I buy shares of Applied Genetic Technologies?

Shares of AGTC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Applied Genetic Technologies' stock price today?

One share of AGTC stock can currently be purchased for approximately $6.43.

How big of a company is Applied Genetic Technologies?

Applied Genetic Technologies has a market capitalization of $165.64 million and generates $41.69 million in revenue each year. The biotechnology company earns $-2,010,000.00 in net income (profit) each year or ($0.11) on an earnings per share basis. Applied Genetic Technologies employs 85 workers across the globe.

What is Applied Genetic Technologies' official website?

The official website for Applied Genetic Technologies is www.agtc.com.

How can I contact Applied Genetic Technologies?

Applied Genetic Technologies' mailing address is 14193 NW 119TH TERRACE SUITE 10, ALACHUA FL, 32615. The biotechnology company can be reached via phone at 386-462-2204.

This page was last updated on 7/3/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.